Quote | Evaxion Biotech A/S (NASDAQ:EVAX)
Last: | $2.76 |
---|---|
Change Percent: | -3.57% |
Open: | $2.9 |
Close: | $2.76 |
High: | $2.93 |
Low: | $2.64 |
Volume: | 13,765 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
News | Evaxion Biotech A/S (NASDAQ:EVAX)
Central AI-Immunology™ Building Block: Evaxion’s proprietary in-house developed building block, EvaxMHC, is used across the AI-Immunology™ platform Improved Performance: Utilizing a state-of-the-art novel deep-learning framework as well as training on public and...
COPENHAGEN, Denmark, July 03, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today issued the following letter to shareholders...
Message Board Posts | Evaxion Biotech A/S (NASDAQ:EVAX)
Subject | By | Source | When |
---|---|---|---|
Back inside the bollinger. Watching to reload. | BooDog | investorshub | 04/18/2023 2:23:15 PM |
$EVAX 1.49. 50 DMA support @ 1.33. | BooDog | investorshub | 04/17/2023 2:03:07 PM |
Took a few more here. Like how | BooDog | investorshub | 04/13/2023 4:42:51 PM |
$EVAX......................................https://stockcharts.com/h-sc/ui?s=$EVAX | glenn1919 | investorshub | 02/08/2023 1:43:58 PM |
1.64 Some may think this is a discount. | BooDog | investorshub | 01/04/2023 1:31:56 PM |
News, Short Squeeze, Breakout and More Instantly...
Central AI-Immunology™ Building Block: Evaxion’s proprietary in-house developed building block, EvaxMHC, is used across the AI-Immunology™ platform Improved Performance: Utilizing a state-of-the-art novel deep-learning framework as well as training on public and...
COPENHAGEN, Denmark, July 03, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today issued the following letter to shareholders...
Positive Feedback Received: An International Preliminary Report on Patentability (IPRP) indicates promising prospects for obtaining granted patents and protecting the invention Unique Attributes and Inventiveness: The feedback highlights the distinct and inventive nature of all rele...